Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Former Novartis pharmaceuticals chief David Epstein is going biotech
9 years ago
Julian Adams jumps ship from a deeply troubled Infinity Pharma
9 years ago
Alessandro Riva exits top Novartis oncology post, heads to a troubled — but wealthy — Gilead
9 years ago
Provectus boots its interim CEO following expense probe, 10 months after founder left under the same cloud
9 years ago
Surprise! Biogen goes with commercial chief Vounatsos in replacing CEO Scangos
9 years ago
Innate Pharma woos Mondher Mahjoubi away from AstraZeneca’s cancer research ops to take the helm
9 years ago
Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?
9 years ago
As FDA assesses its antibiotic, Cempra bids longtime CEO Prabha Fernandes goodbye
9 years ago
Alexion CEO, CFO make a sudden exit as internal fraud probe explodes into a crisis
9 years ago
Sayonara Novartis: Ex-cell therapy chief challenges CAR-T leaders, moves to Carl June’s biotech startup
9 years ago
Startups
Yes, Martin Shkreli can drop his bad boy persona, at least for one moment
9 years ago
A disruptive billionaire with a yen for innovation herds top researchers into a neoantigen cancer coalition
9 years ago
R&D
Stubborn Actelion CEO Clozel spurs shift in buyout talks, but J&J counters with a raised bid -- reports
9 years ago
Pharma
Novartis’ recently departed oncology R&D chief is headed back to Dana-Farber and a new job in cancer research
9 years ago
Donald Trump is starting to win over biopharma
9 years ago
Pharma
Biotech insider Rich Bagger is out, Gingrich is up in latest reshuffle of Trump’s inner circle
9 years ago
Pharma
Donald Trump sends a vaguely worded love letter to biopharma as stock rally continues
9 years ago
Pharma
Kite CEO Arie Belldegrun preps for a looming date with the FDA as he tackles first-mover advantage in CAR-T
9 years ago
Pharma
Post-merger, gene therapy player Adverum makes Amber Salzman CEO, delays a clinical trial start
9 years ago
R&D
The Sarepta dilemma: Bioethics expert Arthur Caplan says it’s time to rethink how to regulate compassion
9 years ago
Pharma
Can We Conquer All Diseases By The End Of The Century? An Interview with Chan Zuckerberg's Cori Bargmann.
9 years ago
André Choulika on gene editing: "If you marry yourself to a technology, you're doomed."
9 years ago
Presto! Wall Street magician Vivek Ramaswamy has another instant biotech IPO to sell you
9 years ago
Financing
UniQure CEO Soland makes a quick exit as execs hammer out a new strategy
9 years ago
Pharma
First page
Previous page
97
98
99
100
101
Next page
Last page